Each filer's latest filing for M7S64L123 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Oak HC/FT Partners II, L.P.
13D/A
|
6.0% |
9/22/2025
Event 9/18/2025
|
||
| Oak HC/FT Partners II, L.P. | 3.2% | |||
| Oak HC/FT Associates II, LLC | 3.2% | |||
| Oak HC/FT Partners V, L.P. | 2.0% | |||
| Oak HC/FT Partners V-A, L.P. | 0.5% | |||
| Oak HC/FT Partners V-B, L.P. | 0.4% | |||
| Oak HC/FT Associates V, L.P. | 2.9% | |||
| Oak HC/FT GP V, LLC | 2.9% | |||
| Ann H. Lamont | 6.0% | |||
| Andrew W. Adams | 6.0% | |||
| Frontier Capital Management Co LLC 13G | 5.0% |
11/16/2026
Event 9/30/2026
|
||
|
American Century Investment Management, Inc.
13G
|
5.0% |
11/16/2026
Event 9/30/2026
|
||
| American Century Investment Management, Inc. | 5.0% | |||
| American Century Companies, Inc. | 5.0% | |||
| Stowers Institute for Medical Research | 5.0% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
| Frontier Capital Management Co LLC 13G/A | 4.1% |
8/14/2025
Event 6/30/2025
|
||
| BlackRock, Inc. 13G/A | 3.6% |
4/24/2025
Event 3/31/2025
|
||
|
Viola Ventures V.C. Management 4 Ltd.
13G/A
|
0.8% |
11/13/2025
Event 9/30/2025
|
||
| Viola Ventures IV (A) L.P. | 0% | |||
| Viola Ventures IV (B) L.P. | 0% | |||
| Viola Ventures IV Principals Fund L.P. | 0% | |||
| Viola Ventures IV CEO Program L.P. | 0% | |||
| Viola 4 P, Limited Partnership | 0% | |||
| Viola Ventures 4 L.P. | 0% | |||
| Viola Ventures 4 Ltd. | 0% | |||
| Viola Ventures V.C. Management 4 Ltd. | 0% | |||
| Avi Zeevi | 0.8% | |||
| Harel Beit-On | 0.4% | |||
| Shlomo Dovrat | 0.4% | |||
|
GIC Private Ltd
13D/A
|
0.6% |
7/2/2025
Event 6/30/2025
|
||
| GIC Private Ltd | 0.6% | |||
| GIC Asset Management Pte. Ltd | 0.6% | |||
| Radiance Star Pte. Ltd. | 0.6% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 233 | 41.3 M | $716M |
| 2026 Q2 | 229 | 32.7 M | $593M |
| 2026 Q1 | 222 | 36.9 M | $427M |
| 2025 Q4 | 245 | 42.4 M | $883M |
| 2025 Q3 | 237 | 42.4 M | $1.26B |
| 2025 Q2 | 167 | 35.7 M | $758M |
| 2025 Q1 | 138 | 24.8 M | $260M |
| 2024 Q4 | 132 | 21.9 M | $203M |
| 2024 Q3 | 118 | 19.8 M | $209M |
| 2024 Q2 | 104 | 15.6 M | $199M |
| 2024 Q1 | 80 | 12.4 M | $119M |
| 2023 Q4 | 1 | 8.66 M | $12.0M |
| 2023 Q3 | 1 | 15.6 M | $24.6M |
| 2023 Q2 | 1 | 8.98 M | $12.6M |
| 2023 Q1 | 1 | 4.98 M | $5.08M |